Please login to the form below

Not currently logged in

blood disorders

This page shows the latest blood disorders news and features for those working in and with pharma, biotech and healthcare.

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Tau is emerging as a target for drug development in Alzheimer’s as well as other disorders like frontotemporal dementia. ... trial of Vertex and CRISPR Therapeutics’ CTX001 in blood disorders last November.

Latest news

More from news
Approximately 2 fully matching, plus 36 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Products as portfolios: positioning immuno-oncology products

    The cancer landscape is changing. Immunotherapeutic advances are driving significant improvements in treatment options for sufferers of many types of cancers and blood disorders. ... Within blood cancers, PD-(L) 1s and also monoclonal antibodies, in

  • Life keeps on growing

    Previously Kirsty worked on MedEd accounts at Adventis Health. During her marketing degree she also spent a year at Baxter Healthcare as a marketing executive working on rare blood disorders.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....